Human regulatory T cells against minor histocompatibility antigens: Ex vivo expansion for prevention of graft-versus-host disease

Blood

Volumn 122, Issue 13, 2013, Pages 2251-2261

  Veerapathran, Anandharaman ^a   Pidala, Joseph ^a   Beato, Francisca ^a   Betts, Brian ^a   Kim, Jongphil ^b   Turner, Joel G ^a   Hellerstein, Marc K ^c,d   Yu, Xue Zhong ^a   Janssen, William ^a   Anasetti, Claudio ^a  

^a Department of Blood and Marrow Transplantation ^*  (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; HY ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2; MINOR HISTOCOMPATIBILITY ANTIGEN; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR;

ALLOREACTIVE T CELL; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE RELEASE; DEMETHYLATION; DENDRITIC CELL; EX VIVO STUDY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; HUMAN CELL; LEUKAPHERESIS; MOLECULAR CLONING; MONOZYGOTIC TWINS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY T LYMPHOCYTE; ALLOTRANSPLANTATION; COCULTURE; CULTURE TECHNIQUE; CYTOLOGY; FEMALE; IMMUNOLOGY; MALE; METHODOLOGY; SIBLING;

CELL CULTURE TECHNIQUES; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HUMANS; MALE; MINOR HISTOCOMPATIBILITY ANTIGENS; SIBLINGS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84887347546     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-03-492397     Document Type: Article

References (55)

1. Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012;12(6):443- 458.
2. Warren EH, Zhang XC, Li S, et al. Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. Blood. 2012;120(14): 2796-2806.
3. Ferrara JL, Levine JE, Reddy P, Holler E. Graftversus- host disease. Lancet. 2009;373(9674): 1550-1561.
4. Vogt MH, de Paus RA, Voogt PJ, Willemze R, Falkenburg JH. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood. 2000;95(3):1100-1105.
5. Vogt MH, Goulmy E, Kloosterboer FM, Blokland E, de Paus RA, Willemze R, Falkenburg JH. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood. 2000; 96(9):3126-3132.
6. Vogt MH, van den Muijsenberg JW, Goulmy E, et al. The DBY gene codes for an HLA-DQ5- restricted human male-specific minor histocompatibility antigen involved in graftversus- host disease. Blood. 2002;99(8):3027-3032.
7. Wang W, Meadows LR, den Haan JM, et al. Human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein. Science. 1995;269(5230):1588-1590.
8. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775-787.
9. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-Tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-Tolerance causes various autoimmune diseases. J Immunol. 1995;155(3): 1151-1164.
10. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD41CD251 regulatory T cells. Nat Immunol. 2003;4(4):330-336.
11. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057-1061.
12. Ng WF, Duggan PJ, Ponchel F, et al. Human CD4(1)CD25(1) cells: A naturally occurring population of regulatory T cells. Blood. 2001; 98(9):2736-2744.
13. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(1)CD25(1) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99(10):3493-3499.
14. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-Type CD4(1)CD25(1) regulatory T cells suppress lethal acute graftversus- host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196(3):389-399.
15. Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL, Cohen JL. Recipienttype specific CD41CD251 regulatory T cells favor immune reconstitution and control graftversus- host disease while maintaining graftversus- leukemia. J Clin Invest. 2003;112(11): 1688-1696.
16. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS. CD41 CD251 regulatory T cells preserve graft-versustumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med. 2003;9(9):1144-1150.
17. Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM. CD251 CD41 T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med. 2004;199(11):1467-1477.
18. Veerapathran A, Pidala J, Beato F, Yu XZ, Anasetti C. Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly. Blood. 2011;118(20):5671-5680.
19. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL. CD4(1)CD25(1) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med. 2002;196(3):401-406.
20. Godfrey WR, Ge YG, Spoden DJ, Levine BL, June CH, Blazar BR, Porter SB. In vitro-expanded human CD4(1)CD25(1) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood. 2004;104(2):453-461.
21. Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M. Large-scale in vitro expansion of polyclonal human CD4(1)CD25high regulatory T cells. Blood. 2004;104(3):895-903.
22. Albert MH, Liu Y, Anasetti C, Yu XZ. Antigendependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation. Eur J Immunol. 2005;35(9): 2598-2607.
23. Golshayan D, Jiang S, Tsang J, Garin MI, Mottet C, Lechler RI. In vitro-expanded donor alloantigen-specific CD41CD251 regulatory T cells promote experimental transplantation tolerance. Blood. 2007;109(2):827-835.
24. Nishimura E, Sakihama T, Setoguchi R, Tanaka K, Sakaguchi S. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp31CD251CD41 regulatory T cells. Int Immunol. 2004;16(8):1189-1201.
25. Bleakley M, Otterud BE, Richardt JL, et al. Leukemia-Associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD81 T cells. Blood. 2010;115(23):4923-4933.
26. Strauss L, Czystowska M, Szajnik M, Mandapathil M, Whiteside TL. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin. PLoS ONE. 2009;4(6):e5994.
27. Hellerstein M, Hanley MB, Cesar D, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med. 1999;5(1):83-89.
28. McCune JM, Hanley MB, Cesar D, et al. Factors influencing T-cell turnover in HIV-1-seropositive patients. J Clin Invest. 2000;105(5):R1-R8.
29. Busch R, Neese RA, Awada M, Hayes GM, Hellerstein MK. Measurement of cell proliferation by heavy water labeling. Nat Protoc. 2007;2(12): 3045-3057.
30. Givan AL, Fisher JL, Waugh MG, Bercovici N, Wallace PK. Use of cell-Tracking dyes to determine proliferation precursor frequencies of antigen-specific T cells. Methods Mol Biol. 2004; 263:109-124.
31. Wieczorek G, Asemissen A, Model F, et al. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res. 2009;69(2):599-608.
32. den Haan JM, Sherman NE, Blokland E, et al. Identification of a graft versus host diseaseassociated human minor histocompatibility antigen. Science. 1995;268(5216):1476-1480.
33. Goulmy E, Gratama JW, Blokland E, Zwaan FE, van Rood JJ. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature. 1983;302(5904):159-161.
34. Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer. 2004;4(5):371-380.
35. Warren EH, Gavin MA, Simpson E, et al. The human UTY gene encodes a novel HLA-B8- restricted H-Y antigen. J Immunol. 2000;164(5): 2807-2814.
36. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531-564.
37. Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007;450(7169):566-569.
38. Bardel E, Larousserie F, Charlot-Rabiega P, Coulomb-L'Hermine A, Devergne O. Human CD41 CD251 Foxp31 regulatory T cells do not constitutively express IL-35. J Immunol. 2008; 181(10):6898-6905.
39. Schwarer AP, Jiang YZ, Brookes PA, Barrett AJ, Batchelor JR, Goldman JM, Lechler RI. Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versushost disease after HLA-identical sibling bonemarrow transplantation. Lancet. 1993;341(8839): 203-205.
40. Dickinson AM, Sviland L, Wang XN, Jackson G, Taylor PR, Dunn A, Proctor SJ. Predicting graftversus- host disease in HLA-identical bone marrow transplant: A comparison of T-cell frequency analysis and a human skin explant model. Transplantation. 1998;66(7):857-863.
41. Theobald M, Nierle T, Bunjes D, Arnold R, Heimpel H. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N Engl J Med. 1992;327(23):1613-1617.
42. Ukena SN, Velaga S, Goudeva L, et al. Human regulatory T cells of G-CSF mobilized allogeneic stem cell donors qualify for clinical application. PLoS ONE. 2012;7(12):e51644.
43. Riley JL, June CH, Blazar BR. Human T regulatory cell therapy: Take a billion or so and call me in the morning. Immunity. 2009;30(5): 656-665.
44. Sagoo P, Ali N, Garg G, Nestle FO, Lechler RI, Lombardi G. Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci Transl Med. 2011;3(83): 83ra42.
45. Hoffmann P, Eder R, Boeld TJ, Doser K, Piseshka B, Andreesen R, Edinger M. Only the CD45RA1 subpopulation of CD41CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood. 2006;108(13): 4260-4267.
46. Di Ianni M, Falzetti F, Carotti A, et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood. 2011;117(14):3921-3928.
47. Zeiser R, Leveson-Gower DB, Zambricki EA, et al. Differential impact of mammalian target of rapamycin inhibition on CD41CD251Foxp31 regulatory T cells compared with conventional CD41 T cells. Blood. 2008;111(1):453-462.
48. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 2011;117(3): 1061-1070.
49. Moss PA, Rowland-Jones SL, Frodsham PM, McAdam S, Giangrande P, McMichael AJ, Bell JI. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sci USA. 1995;92(13):5773-5777.
50. Pilling D, Akbar AN, Bacon PA, Salmon M. CD41 CD45RA1 T cells from adults respond to recall antigens after CD28 ligation. Int Immunol. 1996; 8(11):1737-1742.
51. Valmori D, Tosello V, Souleimanian NE, Godefroy E, Scotto L, Wang Y, Ayyoub M. Rapamycinmediated enrichment of T cells with regulatory activity in stimulated CD41 T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD41 T cells. J Immunol. 2006;177(2):944-949.
52. Scotta C, Esposito M, Fazekasova H, et al. Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD41CD251FOXP31 Treg subpopulations. Haematologica. 2013;98(8): 1291-1299.
53. Golovina TN, Mikheeva T, Brusko TM, Blazar BR, Bluestone JA, Riley JL. Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells. PLoS ONE. 2011;6(1):e15868.
54. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272(5258):60-66.
55. Baron U, Floess S, Wieczorek G, et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(1) conventional T cells. Eur J Immunol. 2007;37(9):2378-2389.